An Open-Label Study to Evaluate Retreatment With LIPO-202
Status unconfirmed · Phase 2
Conditions studied: Central Abdominal Bulging
In brief
Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients who have central abdominal bulging. Efficacy measurements will also be collected.
Key facts
- Study ID
- NCT02397525
- Run by
- Neothetics, Inc
- People needed
- 150
- Starts
- 2015-03-01
- Last updated by the study team
- 2015-08-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Provided consent
- Healthy male or non-pregnant female subjects
- BMI < 30 kg/m2
- Stable diet and exercise routine
- Central abdominal bulging that is at least "Slight Bulge, Not Flat"
You may not qualify if…
- Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen
- Plan on starting a weight loss or exercise program during the study.
- Be a woman who is pregnant, breast feeding, have had a baby within 6 months and/or not using appropriate birth control.
- Known hypersensitivity to study drugs
- Prior or current enrollment in any Neothetics (formerly Lithera) study involving LIPO-102 or LIPO-202
Where it is running
- AboutSkin Dermatology — Englewood, Colorado, United States
- Dermatology Research Institute, LLC — Coral Gables, Florida, United States
- Gwinnett Clinical Research Center, Inc — Snellville, Georgia, United States
- Lupo Center for Aesthetic and General Dermatology — New Orleans, Louisiana, United States
- Bass Plastic Surgery PLLC — New York, New York, United States
- DermResearch Center of New York — Stony Brook, New York, United States
- Dermatology Clinical Research Center of San Antonio — San Antonio, Texas, United States
- Charlottesville Medical Research — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.